Related Experiment Video
Updated: Jul 16, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
How have the past 5 years of research changed clinical practice in paediatric nephrology?
1Great Ormond Street Hospital for Children NHS Trust, Great Ormond Street, London WC1N 3JH, UK. markss2@gosh.nhs.uk
Insights
Paediatric nephrology advances improve diagnosis and management of kidney diseases in children. Evidence-based treatments and renal transplantation reduce morbidity and mortality, enhancing long-term outcomes.
Area of Science:
- Pediatric Nephrology
- Genetics and Molecular Biology
- Renal Medicine
Background:
- Clinical practice in pediatric nephrology is rapidly advancing, driven by 21st-century research.
- Management of congenital renal anomalies, urinary tract infections, nephrotic syndrome, and hypertension is increasingly evidence-based.
- Obesity-related hypertension is a growing focus in primary and secondary care.
Purpose of the Study:
- To highlight the evolving landscape of pediatric nephrology.
- To emphasize advancements in diagnosis, treatment, and management of pediatric kidney diseases.
- To discuss the impact of genetic discoveries and improved therapeutic strategies.
Main Methods:
- Review of current clinical practices and research in pediatric nephrology.
- Integration of evidence-based guidelines for managing common pediatric renal conditions.
- Discussion of emerging diagnostic tools and therapeutic interventions.
Main Results:
- Improved prenatal diagnosis through molecular and cytogenetic advancements.
- Effective medical management to delay chronic kidney disease progression and reduce proteinuria.
- Renal transplantation as the preferred treatment for end-stage renal failure, with dialysis modalities evolving.
- Advancements in imaging technologies like MRI and CT scans.
- Focus shifting towards reducing morbidity and preventing long-term complications like atherosclerosis.
Conclusions:
- Paediatric nephrology is characterized by significant progress in evidence-based management and treatment strategies.
- Genetic discoveries are enhancing prenatal diagnosis and understanding of kidney diseases.
- Renal transplantation and evolving dialysis techniques offer improved outcomes for children with end-stage renal failure.
- Ongoing clinical trials are yielding more effective treatments, reducing disease-related morbidity and drug side effects.
Abstract:
Clinical practice in paediatric nephrology is continuously evolving to mirror the research output of the 21st century. The management of antenatally diagnosed renal anomalies, urinary tract infections, nephrotic syndrome and hypertension is becoming more evidence based. Obesity and related hypertension is being targeted at primary and secondary care. The evolving field of molecular and cytogenetics is discovering genes that are facilitating clinicians and families with prenatal diagnoses and understanding of disease processes. The progression of chronic kidney disease in childhood to end-stage renal failure (ESRF) can be delayed using medical treatment to reduce proteinuria and treat hypertension. Pre-emptive living-related renal transplantation has become the treatment of choice for children with ESRF, thereby reducing the morbidity and mortality associated with peritoneal and haemodialysis. Although peritoneal dialysis, which is performed in the patient's home, is the preferred modality for children for whom there is no living or deceased donor for transplantation, home nocturnal haemodialysis is becoming a feasible option. Imaging modalities with the use of magnetic resonance and computerised tomography are continuously improving. As mortality for renal and vasculitic diseases improves, the gauntlet is now thrown down to reduce morbidity with secondary prevention of longer-term complications such as atherosclerosis and hyperlipidaemia. Clinical and drug trials in the fields of hypertension, nephrotic syndrome, systemic lupus erythematosus, vasculitis and transplantation are producing more effective treatments, thereby reducing the morbidity resulting from the disease processes and the side effects of drugs.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Distribution
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions